Equip Your Preclinical I/O Studies with Robust Models to Enable Enhanced Clinical Relevancy & Translatability

As the only industry-focused meeting dedicated to preclinical scientists and translational oncologists in the immunotherapy space, the PREDiCT Series is once again delighted to bring to you Tumor Models San Francisco 2021, albeit with a new name.

Running in a digital capacity this year, the 5th PREDiCT: Tumor Models for Immuno-Oncology 2021 Summit enables you to discover the latest I/O preclinical strategies in the biopharmaceutical industry, evaluate & debate next-generation preclinical models for immuno-oncology studies and form high-quality connections to ensure cooperation and collaboration stays alive in a socially-distant world.

Offering a wide range of content-driven presentations, expert-led Q&A and discussion, interactive workshops, and the provision of networking opportunity, benchmark against your fellow colleagues to advance your I/O candidates towards the clinic.

Download the full program for more information on sessions and the expert speaker faculty.

"This was a great conference for staying on top of some of the latest developments in IO models and getting a better understanding of the various models, their utility and limitations. The size of the conference allows for many fruitful discussions and ease of meeting with several of the major CROs that provide models for those in the immuno-oncology space."

Michael Mattie, Associate Director, Translational Medicine, Kite Pharma

Expert Speakers at the 2021 PREDiCT: Tumor Models for Immuno-Oncology Summit include:

Jason O’Rourke

Associate Director – In Vivo Pharmacology

Fate Therapeutics

Johanna Lahdenranta

Director – In Vivo Pharmacology

Bicycle Therapeutics

Nadege Morisot

Senior Scientist

Nkarta Therapeutics

Senior Representative

The Jackson Laboratory

Alwin Schuller

Senior Principal Scientist

AstraZeneca

David Langenau

Professor

Massachusetts General Hospital

Dean Campbell

Director – Scientific Engagement

CrownBio

Natalia Malkova

Senior Principal Scientist

Sanofi

2021 Official Sponsors:

Jackson-Laboratory
Crown
Certis-Logo
Covance
studylog_logo-tag-cropped